What is Telnet-Rx?
Telnet-Rx specializes in providing 24-hour remote order entry pharmacy services, encompassing pharmacy management, staffing, and expert consultation. The company's innovative solutions are designed to enhance medication safety and optimize staffing efficiency for a diverse clientele, including hospitals, retail pharmacies, long-term care facilities, and rehabilitation centers. By leveraging technology and adhering to stringent regulatory compliance, Telnet-Rx aims to improve the overall performance and effectiveness of pharmacy operations, positioning itself as a key player in the evolving healthcare technology landscape.
How much funding has Telnet-Rx raised?
Telnet-Rx has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Telnet-Rx
PPP
Public-Private Partnership
What's next for Telnet-Rx?
The recent strategic investment signals a pivotal moment for Telnet-Rx, likely enabling the company to accelerate its growth initiatives, expand its service offerings, and potentially broaden its market reach. As a company operating in the late-stage funding environment, this capital infusion is expected to fuel further technological advancements and operational scaling, solidifying its competitive advantage in the telepharmacy market and supporting its mission to enhance pharmaceutical care delivery nationwide.
See full Telnet-Rx company page
